In the DOX-nano group, the weight of the tumor tissues were significantly lighter, and the expression of multidrug resistance-related proteins, including MRP, LRP, BCRP, Bcl-2, and PKC-α was significantly lower. The gene discussed is C19orf48P; the disease is neoplasm.